Boryung restarts Yonggaksan advertisement

Published: 2007-03-13 06:57:00

Updated: 2007-03-13 06:57:00

Boryung Pharm said it will re-initiate the advertisement of its famous OTC brand Yonggaksan, antitussive & expectorant, in just 12 years after the company stopped its advertisement.

The company is aiming to bite bigger sales of Yonggaksan as part of its OTC promotion strategies, as the yellow ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK